REG - Inspiration Health - Board Changes

Inspiration HealthcareAnnouncement

05/12/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221205:nRSE5185Ia&default-theme=true

RNS Number : 5185I  Inspiration Healthcare Group PLC  05 December 2022

 

 

 

Inspiration Healthcare Group plc

 

 

Board Changes

Inspiration Healthcare Group plc (AIM: IHC) ("Inspiration Healthcare" or the
"Company"), the global medical technology company today, announces that Mr
Jonathan Ballard has stepped down from the role of Chief Financial Officer
with immediate effect. The Board has secured an experienced practitioner, who
is currently acting as a consultant to the Company and who has significant
prior knowledge of Inspiration Healthcare, to lead the finance team on an
interim basis. Mr Ballard will remain with the Company during his notice
period, to ensure an orderly transition whilst the Company recruits his
permanent successor.  The Board wishes to thank Mr Ballard for his hard work
and dedication over the past five years.

 

This announcement contains inside information.

 

Enquiries:

 

 Inspiration Healthcare Group plc                                                                                                                                                       Tel: 0330 175 0000

 Neil Campbell, Chief Executive Officer

 Nominated Adviser & Broker                                                                                                                                                             Tel: 0207 397 8900

 Cenkos Securities plc

 Stephen Keys

 Mark Connelly

 Katy Birkin

 Dan Hodkinson
 Cadogan                                                                                                                                                                                Tel: 07771 713608
 PR

 Alex Walters

 alex.walters@cadoganpr.com (mailto:alex.walters@cadoganpr.com)

 

 

About Inspiration Healthcare Group

 

www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk/)

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in critical care & operating theatres. The Company provides
high-quality, innovative products to patients around the world which help to
improve patient outcomes, and it actively invests in innovative product
opportunities and disruptive technologies.

 

The Group currently consists of three companies: Inspiration Healthcare Ltd,
SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal
intensive care and operating theatre equipment around the work through a
network of distributors into over 75 countries.  Products range from highly
sophisticated capital equipment through to single use disposables all that can
help improve outcomes of extremely sick patients.

 

In the UK and Ireland the Group offers direct sales for most of its products
supported by Technical Service offering on site and return to base repair and
maintenance along with 24/7 emergency hire of equipment and long term lease
arrangements for its own brand products.  The Group also acts as a
distributor for 3(rd) party companies that wish to access the NHS using the
Group's sales and service expertise and knowledge of the NHS

 

The Group invests in growth through Research and Development holding numerous
patents on its technology and has strong links with academic Key Opinion
Leaders around the world and supports clinical research in the field of
neonatal intensive care.

 

Further information on Inspiration Healthcare Group plc can be seen
at  www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAUSSSRUVUURAA